The Multi-scale brain

EPFL, located in the Lausanne area, is a leading European research university focused on science, engineering and technology. Founded in 1853, the school is renowned for interdisciplinary research, strong ties to industry and an entrepreneurial ecosystem that supports hundreds of startups. Students encounter a rigorous curriculum that emphasizes hands-on projects, collaboration and the translation of research into practical solutions.

The campus offers state of the art laboratories, innovation hubs and close partnerships with industry leaders in robotics, AI, sustainable energy and biotechnology. International students join a diverse community and benefit from programs taught in English, extensive research opportunities and structured doctoral and masters pathways. EPFL s connections with Swiss industry create clear pipelines for internships, collaborative theses and employment after graduation.

Life at EPFL blends academic intensity with a supportive environment that includes career services, language support and student associations. Lausanne s location on Lake Geneva provides a high quality of life and plentiful outdoor activities while remaining central to European research networks. Applicants should highlight research interests, teamwork experience and readiness for an intensive, innovation driven academic setting.

The Multi-scale brain is a non-degree program for international students, offered by École polytechnique fédérale de Lausanne (EPFL) in Switzerland. It's a 1-week program taught in English, open to students with a pre-high school education level.

This program covers specific subjects related to brain function and development, helping students develop skills in neuroscience and research methods. Hands-on components include laboratory work and experiments.

After completing this program, students can pursue careers as Research Assistants, Neuroscience Lab Technicians, or Science Writers, working in industries such as healthcare, education, or research institutions, including companies like Novartis or the Swiss Federal Institute of Technology.